JP2023549765A5 - - Google Patents
Info
- Publication number
- JP2023549765A5 JP2023549765A5 JP2023528001A JP2023528001A JP2023549765A5 JP 2023549765 A5 JP2023549765 A5 JP 2023549765A5 JP 2023528001 A JP2023528001 A JP 2023528001A JP 2023528001 A JP2023528001 A JP 2023528001A JP 2023549765 A5 JP2023549765 A5 JP 2023549765A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- optionally
- cell
- lymphoma
- tcr
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063110851P | 2020-11-06 | 2020-11-06 | |
| US63/110,851 | 2020-11-06 | ||
| US202063111462P | 2020-11-09 | 2020-11-09 | |
| US63/111,462 | 2020-11-09 | ||
| US202063129804P | 2020-12-23 | 2020-12-23 | |
| US63/129,804 | 2020-12-23 | ||
| US202163175350P | 2021-04-15 | 2021-04-15 | |
| US63/175,350 | 2021-04-15 | ||
| PCT/US2021/058382 WO2022099100A2 (en) | 2020-11-06 | 2021-11-08 | Binding proteins recognizing ha-1 antigen and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023549765A JP2023549765A (ja) | 2023-11-29 |
| JP2023549765A5 true JP2023549765A5 (cg-RX-API-DMAC7.html) | 2024-11-18 |
Family
ID=81458633
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023528001A Pending JP2023549765A (ja) | 2020-11-06 | 2021-11-08 | Ha-1抗原を認識する結合タンパク質及びその使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230398217A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4240490A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023549765A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230117576A (cg-RX-API-DMAC7.html) |
| AU (3) | AU2021323388C1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3197255A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL302616A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023005179A (cg-RX-API-DMAC7.html) |
| TW (1) | TW202227499A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022099100A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024130009A1 (en) * | 2022-12-14 | 2024-06-20 | Yale University | Compositions and methods of use thereof for the treatment of virally driven cancers |
| WO2025217028A1 (en) * | 2024-04-08 | 2025-10-16 | Tscan Therapeutics, Inc. | Magec2 immunogenic peptides, binding proteins recognizing magec2 immunogenic peptides, and uses thereof |
| WO2025217035A2 (en) * | 2024-04-08 | 2025-10-16 | Tscan Therapeutics, Inc. | Use of anti-ha-1 and anti-ha-2 binding proteins for treatment of aml, all, and mds |
| WO2025231299A1 (en) * | 2024-05-02 | 2025-11-06 | Fred Hutchinson Cancer Center | Tcr t cell therapy targeting ha-1 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2013535199A (ja) * | 2010-07-28 | 2013-09-12 | イムノコア リミテッド | T細胞レセプター |
| KR102397771B1 (ko) * | 2016-09-23 | 2022-05-13 | 프레드 헛친슨 켄서 리서치 센터 | 부 조직적합성(h) 항원 ha-1에 대해서 특이적인 tcr 및 이의 용도 |
| WO2020030631A1 (en) * | 2018-08-06 | 2020-02-13 | Medigene Immunotherapies Gmbh | Ha-1 specific t cell receptors and their use |
| NL2021789B1 (en) * | 2018-10-10 | 2020-05-14 | Academisch Ziekenhuis Leiden | Binding proteins specific for HA-1H and uses thereof |
-
2021
- 2021-11-08 WO PCT/US2021/058382 patent/WO2022099100A2/en not_active Ceased
- 2021-11-08 US US18/035,373 patent/US20230398217A1/en active Pending
- 2021-11-08 AU AU2021323388A patent/AU2021323388C1/en active Active
- 2021-11-08 EP EP21890215.3A patent/EP4240490A4/en active Pending
- 2021-11-08 JP JP2023528001A patent/JP2023549765A/ja active Pending
- 2021-11-08 CA CA3197255A patent/CA3197255A1/en active Pending
- 2021-11-08 KR KR1020237018962A patent/KR20230117576A/ko active Pending
- 2021-11-08 IL IL302616A patent/IL302616A/en unknown
- 2021-11-08 MX MX2023005179A patent/MX2023005179A/es unknown
- 2021-11-08 TW TW110141526A patent/TW202227499A/zh unknown
-
2022
- 2022-09-29 AU AU2022241563A patent/AU2022241563B2/en active Active
-
2026
- 2026-01-28 AU AU2026200575A patent/AU2026200575A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024517618A5 (cg-RX-API-DMAC7.html) | ||
| US20230203124A1 (en) | Methods of isolating t cell receptors having antigenic specificity for a cancer-specific mutation | |
| AU2022203507B2 (en) | Methods of isolating T cells and T cell receptors having antigenic specificity for a cancer-specific mutation from peripheral blood | |
| US20240166758A1 (en) | Combination therapies for treatment of bcma-related cancers and autoimmune disorders | |
| AU2021202223B2 (en) | Methods of isolating T cells having antigenic specificity for a cancer-specific mutation | |
| JP7770188B2 (ja) | 養子細胞療法のための標的共刺激を提供する受容体 | |
| MacDonald et al. | Alloantigen-specific regulatory T cells generated with a chimeric antigen receptor | |
| JP2023534808A (ja) | 養子細胞療法のための標的共刺激を提供する受容体 | |
| CA3144070A1 (en) | T cell receptors recognizing r175h or y220c mutation in p53 | |
| CN115747156A (zh) | 用于得到体内存留性和治疗活性的nkt细胞亚群以及其繁殖 | |
| JP2024546018A5 (cg-RX-API-DMAC7.html) | ||
| JP2024515646A5 (cg-RX-API-DMAC7.html) | ||
| US20220064257A1 (en) | Specific t cell receptors against epitopes of mutant myd88l265p protein for adoptive t cell therapy | |
| Jaigirdar et al. | A high avidity WT1 reactive T cell receptor mediates recognition of peptide and processed antigen but not naturally occurring WT1 positive tumor cells | |
| Nakatsugawa et al. | CD4+ and CD8+ TCRβ repertoires possess different potentials to generate extraordinarily high-avidity T cells | |
| JP2025516264A5 (cg-RX-API-DMAC7.html) | ||
| TW202406569A (zh) | 多重t細胞受體組合物、組合療法及其用途 | |
| US20240360236A1 (en) | Methods for targeted immunotherapy of acute myeloid leukemia (aml) | |
| EP4223782A1 (en) | Novel t cell receptors and immune therapy using the same for the treatment of cancer | |
| Cereb et al. | Induction of microvariant-specific CTL lines reactive to a single amino acid mismatch in bulk cultures using a transfectant expressing a single HLA class I molecule | |
| TW202602496A (zh) | 抗ha-1及抗ha-2結合蛋白用於治療aml、all及mds之用途 | |
| Plewa | Generation of TGFβR2 (-1) neoantigen-specific human T cell receptors from transgenic mice | |
| Ortaldoª | Identification of a proposed NK receptor | |
| Jin et al. | Activation of CD8+ T cells by allogeneic class II‐deficient B‐cell lines derived from patients with bare lymphocyte syndrome | |
| Lee et al. | Nk-cell immunotherapy for aml |